Skip to main content

Animations

MJFF Publications

1261 - 1270 of 9156 Results
Title
Year
  • Year
  • 2024
  • 2022
  • 2025
  • 2024
  • 2022
  • 2025
  • 2022
  • 2017
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: Clearing the Smoke: What Protects Smokers from Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29707
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28941
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30231
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Constructing and exploring neuroimaging projects: a survey from clinical practice to scientific research
    Journal Name: Insights into Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13244-024-01848-9
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbations
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.13606
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Radioligands Targeting the Purinergic P2X Receptors
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells14130984
    Citation Count: 0
  • Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease
    2022
    Summary Details
    RESTRICTED
    Title: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-017-0154-3
    Citation Count: 266
  • Summary Details
    OPEN
    Title: Public Engagement and Neurology: An Update
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci11040429
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Initiation and propagation of α-synuclein aggregation in the nervous system
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-020-00368-6
    Citation Count: 245
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.